A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee (Q35981425)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee |
scientific article |
Statements
1 reference
A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee (English)
1 reference
Carmichael J
1 reference
Cantwell BM
1 reference
Mannix KA
1 reference
Veale D
1 reference
Elford HL
1 reference
Blackie R
1 reference
Kerr DJ
1 reference
Kaye SB
1 reference
Harris AL
1 reference
1 March 1990
1 reference
1 reference
447-450
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference